Topics

Companies Related to "GlaxoSmithKline AS01E vaccine shows sustained protection against active" [Most Relevant Company Matches] RSS

10:01 EST 6th December 2019 | BioPortfolio

Here are the most relevant search results for "GlaxoSmithKline AS01E vaccine shows sustained protection against active" found in our extensive corporate database of over 50,000 company records.

Showing "GlaxoSmithKline AS01E vaccine shows sustained protection against active" Companies 1–25 of 2,200+

Relevant

Hawaii Biotech, Inc.

Hawaii Biotech, Inc. is a privately held biopharmaceutical company focused on vaccine research and development. The company is targeting first world vaccines with potentially large markets and attractive margins: a West Nile vaccine targeting the U.S. and Canada; and a dengue fever vaccine for travelers from first world countries to dengue endemic areas. The Company’s vaccine technology was feat...


GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette®, NicoDerm®CQ®, and Commit®, as well as many products such as alli®, Aquafresh®, Sensodyne®, and TUMS® -- which are trademarks owned by and/or licensed to GlaxoSmithKline Grou...

Fina Biosolutions

Fina Biosolutions is a privately-owned R&D biotechnology company located in Rockville, MD. The company provides laboratory services and technology in the field of conjugate vaccines. Chemistry developed by Fina Biosolutions scientists is used in GlaxoSmithKline’s pneumococcal conjugate vaccine, Pfizer’s meningococcal conjugate vaccine and others. ...


World of Health Biotech Co.Ltd

Anti HBV Specific Active Immunotherapy (Anti HBV Therapeutic Vaccine) using recombinant hepatitis B vaccine (standard HBV vaccine) as an immunogenic specific antigen and several cytokines as an immune adjuvant is a new antiviral approach for chronic HBV infection. The first and most critical setp in the design of an anti HBV therapeutic vaccine is the selection of the specific antigens that will b...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented at the University of Wisconsin-Madison, in the laboratories of Dr. Yoshihiro Kawaoka and Dr. Gabriele Neumann, and exclusively licensed to FluGen by WARF. The REDEE FLU influenza ...

Otonomy, Inc.

Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. The company's core technology is a sustained release formulation developed for optimal delivery of drugs from a single intratympanic (IT) injection. Broad applicability of this delivery and formulation technology has already been established across a number of therapeuti...

Affinivax Inc.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious diseases. Backed by an investment from the Bill & Melinda Gates Foundation and working with world experts in vaccine discovery and development, Affinivax is focused ...

VBI Vaccines

VBI Vaccines is a biotechnology company dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. VBI’s innovative approach to vaccine development and growing pipeline of vaccine programs address significant market opportunity an...

GlaxoSmithKline & Prosensa

GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com

Variation Biotechnologies Inc

Variation Biotechnologies, Inc. (VBI) creates intelligent vaccines that learn from nature. Our management and scientific team consists of industry-leading experts that have increased our product pipeline and partnerships.After decades of vaccine research, Variosite™ technology evokes the full power of the immune system by mimicking the body's natural protection to infection. This novel vaccine s...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied for various routes of administration including those that provide additional protection in the mucosa, the site where over 90% of pathogens enter the human body. Mucosis’s lead...

Tres Mares Group

Miler Lagos was born in Bogota in 1973. He has had solo shows in the U.S., Puerto Rico, Mexico, Bogota, and group shows all over Latin America, UK, France and Germany.

Sanaria Inc.

Sanaria Inc. was founded in 2003. The company's primary mission is to develop and commercialize attenuated whole-parasite malaria vaccines that confer high-level, long-lasting protection against Plasmodium falciparum, the parasite responsible for most of the malaria-associated severe illness and death worldwide. Sanaria's radiation attenuated sporozoite vaccine, Sanaria(TM) PfSPZ Vaccine, entered...

Affinivax, Inc.

Affinivax is advancing a next generation vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious diseases. Backed by an investment from the Bill & Melinda Gates Foundation, and working with world experts in vaccine discovery and development, Affinivax is focused on creati...

BioVex Inc.

BioVex is a privately held biotechnology company based in Woburn, Mass. where it also has an operational launch grade manufacturing facility. The Company is developing a new class of potent biologics for the treatment of cancer and prevention of infectious disease. In addition to OncoVEX, the Company has a second development program, ImmunoVEX HSV2, ...

Sabin Vaccine Institute

Sabin Vaccine Institute is a 501(c)(3) non-profit organization dedicated to reducing human suffering from infectious and neglected diseases. Through its efforts in vaccine research, development and advocacy, Sabin works to provide greater access to vaccines and essential medicines for millions mired in pain, poverty and despair. Founded in 1993 in honor of Dr. Albert B. Sabin, discoverer of the or...

Inviragen, Inc. and PharmaJet, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease and Japanese encephalitis, both of which affect millions of children in Asia. Vaccines in preclin...

Genetic Immunity, LLC

Genetic Immunity is a biopharmaceutical company focused on therapeutic vaccine development and commercialization. The lead product, DermaVir vaccine patch, is under clinical evaluation in Hungary and in the USA for the treatment for HIV/AIDS, where resistance, toxicity, adherence and cost limit the use of drugs. The Company’s vaccine composition mimics the successful induction of antiviral immun...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2% of the shares of Rhein Biotech, in the year 2002. For more information on Berna Biotech please go to: http://www.bernabiotech.com/company/index.htmlRhein Biotech has been listed on the Frankfurt Sto...

KXBEVENTS

KXBEVENTS was founded in 2007 and specializes in promoting, producing and recording stand-up comedy shows, corporate events and fundraisers. Their television shows are broadcast on Channel 19 Time Warner Cable San Diego every Thursday night at 10:30 p.m. For additional information about KXBEVENTS, contact Klaus Biegler, producer, at info@kxbevents.com.

Geovax Labs

GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining r...

TruMed Systems, Inc.

TruMed Systems, a medical technology company, develops the innovative AccuVax® Vaccine Management System for healthcare professionals. AccuVax is a purpose-built vaccine management solution that safeguards vaccine viability, frees staff time, protects vaccine investment, and maximizes patient safety so that providers can focus on care delivery. AccuVax is ...

Vaxin Inc.

Vaxin Inc. is a clinical stage biotechnology company, founded in December 1997 with facilities in Rockville, MD and Birmingham, AL, developing next generation vaccines to address significant public health and biodefense needs. Vaxin is focused on vaccines designed to protect people against influenza and anthrax infection using proprietary, patented technol...

ACTIPAC Biosystems GmbH

ACTIPAC is offering a novel technology of advanced nano- and micro-encapsulation of sensitive, highly active drugs. Its main focus is the development of controlled release formulations (sustained release).

Biotech Synergy

Biotech Synergy has secured in San Diego the necessary competences to bring this promising multi epitope cancer vaccine to latest stage development. Contrary to Dendreon individualized vaccine, EP-2101 is made of 10 peptides and is an off the shelf readily available vaccine for the HLA-A2 population, which represents 45% of the global NSCLC patients (100,0...


More From BioPortfolio on "GlaxoSmithKline AS01E vaccine shows sustained protection against active"

Quick Search

Corporate Database Quicklinks